KLOW
Retail$2,999.80$2,399.8410-vial kit
Overview
Research-use TB4 / BPC-157 / KPV / GHK-Cu blend supplied for studies of tissue-remodeling, barrier, and inflammatory-signaling pathway models.
- Stock
- In stock
Material profile
KLOW is a research blend composed of TB4 10 mg, BPC-157 10 mg, KPV 10 mg, and GHK-Cu 50 mg for tissue-remodeling, barrier, and inflammatory-signaling pathway studies. Pattern lists this material for controlled laboratory research.
- Research Targets
- Cell-migration pathways, extracellular-matrix remodeling markers, melanocortin-associated immune signaling, copper-peptide collagen pathway models.
- Key Feature
- Multi-compound blend combining TB4, BPC-157, KPV, and GHK-Cu research contexts.
- Research Focus Areas
- Dermal fibroblast models, epithelial barrier signaling, tissue-remodeling pathways, inflammatory cytokine response studies.
- Common Models
- Fibroblast assays, epithelial cell models, wound-pathway research models, matrix-turnover studies.
- Mechanistic Interests
- Actin/cell-migration signaling, cytokine expression markers, collagen pathway markers, redox and tissue-remodeling responses.
- Use Boundary
- Research use only; not for human or veterinary use; no diagnostic, therapeutic, or consumption use is implied.
One kit adds 10 vials to checkout.